Skip to content

TECHNOLOGY COMMERCIALIZATION & IP TRANSACTIONS

Unlock new markets for your technology.

We help technology and patent owners evaluate their IP, uncover commercial and defense applications, and identify potential buyers, licensees and development partners.

Prior-art research • Preliminary freedom-to-operate screening • Market assessment • Targeted outreach

Powered by proprietary software and human-reviewed research.

You control the relationships, negotiations and transaction decisions.

Give your technology portfolio a next step.

Whether you are bringing research to market, representing IP for sale or exploring licensing opportunities, progress takes evidence, positioning and sustained follow-through.
Clearpath adds capacity for patent and scientific-literature prior-art research, claim and patent landscape analysis, preliminary freedom-to-operate screening, market assessment and industry outreach. We connect the findings to practical recommendations for your technology or portfolio.
Start with one technology or a defined portfolio. You receive the evidence, the recommendation and a record of what happens next.

A reviewed recommendation

Advance, Strengthen or Pass, with reasons and gaps.

A ranked buyer and partner landscape

Who to approach, why they fit and where to start.

A managed outreach record

Contact attempts, actual responses and next steps.

Research at scale. Opportunities that need a path to market.

Every year, substantial research investment and hundreds of thousands of patent filings expand the landscape of potential innovation. Turning a technology into a commercial opportunity takes additional work: identifying where it could be used, what needs validation, and which organizations have a reason to engage.

Annual patent activity

MeasureUnited StatesWorldwide
Patent applications filed603,000+3.7 million
Patents granted326,0002.1 million

Note: 2024 invention/utility patent figures, rounded. U.S. figures include domestic and foreign applicants. Counts represent applications and grants, not unique inventions. Applications and grants in the same year are not the same cohort.

Sources: WIPO (opens in a new tab), NSF (opens in a new tab)

U.S. research investment

MeasureFY2024
Federal R&D obligations$194.2 billion
University R&D spending$117.7 billion
Federal funding included in university R&D$64.6 billion

Note: Federal funding is included in university R&D spending. These figures overlap and should not be added. Patent activity above covers all sectors and is not attributed solely to this research funding.

Sources: NSF federal R&D (opens in a new tab), NSF university R&D (opens in a new tab)

The challenge is finding the right application and the right partner.

For larger technology transfer offices, portfolio volume makes it difficult to give every opportunity sustained attention. For smaller teams, limited bandwidth constrains research and outreach.
Promising inventions can remain without a clear commercial path while patent costs accumulate and researchers wait for progress. An application outside the original field—or a potential licensee in an unfamiliar industry—can be easy to overlook.
Clearpath combines proprietary software with human-reviewed research to help uncover commercial and defense applications, prioritize opportunities, and pursue relevant licensees and development partners. Your team retains control of institutional relationships, negotiations and transaction decisions.

What Clearpath does

Assess the Technology

Review prior art, published claims, potential freedom-to-operate concerns and technical readiness.

Define the Market

Identify commercial and defense applications, competing approaches, customer needs and adoption requirements.

Identify the Right Partners

Prioritize potential buyers, licensees and development partners using company-specific evidence and a clear fit rationale.

Advance the Opportunity

Prepare positioning, identify relevant contacts and conduct authorized outreach with follow-up and response tracking.

See our work in action

Explore examples of technology assessments, market research, partner identification and outreach supported by CompassIP.

1 of 44

IP assessment scorecard

Assess IP strengths and gaps with a structured scorecard.

Example screens shown for illustration. They are not live opportunity listings.

How the analysis works

Our proprietary platform connects patent, scientific, company and funding information across three assessments. Human-reviewed findings inform commercialization recommendations and company targeting.
Four patent applications pending.

IP Position & Prior-Art Research

Patent and scientific-literature prior-art research, published-claim analysis, patent landscape review and preliminary freedom-to-operate screening. Identify potential differentiation, third-party patent concerns and evidence gaps.

Commercialization Pathway

Evaluate potential applications, market fit, competing technologies, adoption requirements and routes to market, including licensing, development partnerships, spinouts and sales.

Capital Readiness

Assess development milestones, funding needs, potential grant and non-dilutive funding sources, SBIR/STTR fit and investor alignment.

Partner Targeting

Connect the assessment findings to potential licensees, buyers, development partners and funders. Company research explains the evidence behind each match and helps prioritize further qualification and outreach.

The combined assessment supports an Advance, Strengthen or Pass recommendation, with supporting evidence, limitations and next steps.
Research depth and source coverage depend on the agreed scope and available evidence. Preliminary FTO screening identifies issues for patent counsel's review; it is not a legal opinion or clearance.

Sources include USPTO, EPO, SBIR.gov, SAM.gov, USASpending, SEC EDGAR, Census, BLS and proprietary deal references.

Who Clearpath serves

Technology Transfer Offices

Prioritize disclosures, identify licensees and execute outreach.

IP Brokerages & Corporate IP

Triage portfolios, identify buyers and support monetization.

Accelerators & Investors

Screen cohorts and portfolios by readiness, IP position and fit.

Start with an assessment. Add support as you need it.

Our proprietary software does the data pull and the first pass of analysis in minutes instead of weeks. That's what lets us price this way. A person reviews every finding, makes every call and runs every conversation.

Managed Commercialization

Turn more of your portfolio into active opportunities. Assessment, buyer and licensee targeting, and coordinated outreach for up to ten technologies—from $3,500 per month.

From $3,500 per month

Three-month initial commitment ($10,500 minimum), then month-to-month.

  • Assessment for up to ten named technologies during the initial engagement, completed as work progresses.
  • Buyer and licensee targeting for the named technologies.
  • Coordinated outreach, with responses and opportunities brought back to your team.
  • Up to ten campaigns may operate concurrently; each launches when targeting, materials and written customer authorization are ready.
  • Your organization retains negotiations and transaction decisions.

This is monthly portfolio support, not ten separately purchased campaign packages or ten new technologies each month. Additional technologies and larger portfolios require agreed scope.

Includes the research, target rationale, available contact details, outreach materials, campaign history and recommended next steps, shared during the engagement and consolidated as each campaign is completed.

Assessment offerings

Assess & Prioritize

IP, market and capital-readiness assessment, including prior-art research and preliminary freedom-to-operate screening.

$995

Per technology

Assess + Map

Assessments plus a pathway and partner map.

$1,995 total

Per technology · Assess & Prioritize included · $1,000 upgrade from an existing $995 assessment

Portfolio Assessment & Prioritization

Rank ten technologies by readiness and fit.

$6,500 total

10 technologies in one defined batch · individual assessments and comparative ranking · no outreach

Execute the Campaign

A complete assessment, buyer and licensee map, campaign preparation, and three months of outreach for one technology.

$6,995 complete package

One technology · optional continuation at $2,500 per month

The three-month outreach period begins after campaign materials and targeting are approved and written authorization is received. Assessment and campaign preparation precede that period.

Prior Assess & Prioritize or Assess + Map payments for the same technology are credited toward the package total. CompassIP credit purchases are excluded.

Includes research reports, target companies, identified contacts, outreach history, responses and a consolidated handover.

See Services

Platforms built by Clearpath.

Purpose-built software for evaluating technology, preparing patent materials, and moving opportunities forward.

CompassIP

Assess IP, market opportunity, and capital readiness; identify potential buyers and partners; and organize outreach in one workspace.

CaptureIP

Organize invention disclosures, prepare specifications and claims, and support prosecution workflows with AI-assisted drafts for practitioner review.

CaptureIP prepares drafts for practitioner review; it does not submit filings to the USPTO. Each platform is offered on its own terms.

Clearpath Enterprise

Your own technology commercialization platform.

Clearpath builds and manages platforms tailored to your organization's workflow, from evaluating technology to developing opportunities and connecting with partners.
Built for technology transfer offices, IP brokerages, corporate IP teams, accelerators and investors moving technology toward market.
Bring your workflow. We'll help shape the platform around it.

Sensitive information stays under the owner's control.

Clearpath works from public evidence and owner-approved material. Confidential information is exchanged only after a written agreement, and no counterparty is contacted without written authorization.
Founded by Justin Mahan, a 20-year Air Force veteran and former head of technology partnerships at a corporate consulting firm.

Discuss an asset, a need or an engagement.

First conversations are short and non-confidential.

From evidence to transaction.

SBA-certified veteran-owned business

SBA Certified Service-Disabled Veteran-Owned Small Business (SDVOSB) badgeSBA Certified Veteran-Owned Small Business (VOSB) badge